How Do I Diagnose Pediatric Patients’ Skull Langerhans Cell Histiocytosis Lesions?
Main Article Content
Abstract
Background: Langerhans Cell Histiocytosis (LCH) commonly affects pediatric patients, with skull lesions being frequent. Diagnosis typically requires histopathologic confirmation. While surgical resection has been the standard approach, percutaneous fine needle biopsy (FNB) is emerging as a less invasive alternative.
Objective: To compare diagnostic performance, complications, procedure availability, hospital stay, and lesion regression outcomes between surgical resection and percutaneous FNB for pediatric skull LCH lesions.
Methods: We retrospectively reviewed 35 pediatric cases diagnosed with skull LCH between 2002 and 2024. Diagnostic procedures included surgical resection and percutaneous ultrasound-guided FNB. Data collected included demographics, procedure timing, complications, hospital stay, and follow-up outcomes, with particular focus on lesion regression post-biopsy.
Results: Of 35 cases, 26 underwent surgical resection and 9 underwent FNB. Diagnostic accuracy was 100% for surgery and 89% for FNB. The median time from biopsy request to procedure was significantly shorter for FNB (1 day) compared to surgery (12 days). Complications were more frequent in the surgical group (53.8%), including infections and cranial deformities, while no complications were observed in the FNB group. Notably, 4 cases (11%) showed lesion regression; 2 spontaneously regressed, and 2 others after biopsy, including a temporal bone lesion with central nervous system risk that remained disease-free after 17 years.
Conclusion: Percutaneous FNB is a safe, effective, and less invasive alternative to surgical resection for pediatric skull LCH lesions, offering faster procedure times, fewer complications, and the potential for lesion regression post-biopsy. This supports biopsy as the first-line diagnostic approach when feasible.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Orr T, Lesha E, Dugan JE, et al. Langerhans cell histiocytosis of the sella in a pediatric patient: case report with review of the literature. Child’s Nerv Syst. 2024;40(9):2947-2952. doi:10.1007/s00381-024-06456-y
3. Hughes E, Rosenbaum D, Branson H, et al. Imaging approach to pediatric calvarial bulges. Pediatr Radiol. 2024;54(10):1603-1617. doi:10.1007/s00247-024-05967-9
4. Choudhary G, Udayasankar U, Saade C, Winegar B, Maroun G, Chokr J. A systematic approach in the diagnosis of paediatric skull lesions: what radiologists need to know. Polish J Radiol. 2019;8(84):e92-e111. doi:10.5114/pjr.2019.83101.
5. Haupt R, Minkov M, Astigarraga I et al. Langerhans Cell Histiocytosis (LCH): Guidelines for Diagnosis, Clinical Work-Up, and Treatment for Patients Till the Age of 18 Years. Pediatr Blood Cancer. 2013;60(2):175-184. doi:10.1002/pbc.24367
6. Gerrie SK, Navarro OM, Lyons CJ, et al. Pediatric orbital lesions: bony and traumatic lesions. Pediatr Radiol. 2024;54(6):897-909. doi:10.1007/s00247-024-05882-z
7. Yang J, Huang X, Bao Z, Xu J, Huang H, Huang H. Langerhans cell histiocytosis in children: the value of ultrasound in diagnosis and follow‑up. BMC Med Imaging. 2025;25(29):1-12. doi:10.1186/s12880-025-01563-x
8. Wei M, Jiang W, Wang R, Xiao B, Zhan Q. Langerhans cell histiocytosis of the skull in 23 children. Eur J Med Res. 2024;29(1):1-6. doi:10.1186/s40001-024-01727-5
9. Mavromati M, Caironi V, Saiji E, et al. Langerhans cell histiocytosis of the suprasellar region: diagnosis based on thyroid cytology. Eur Thyroid J. 2024;13(3):1-6. doi:10.1530/ETJ-24-0011
10. Reisi N, Raeissi P, Harati Khalilabad T, Moafi A. Unusual sites of bone involvement in Langerhans cell histiocytosis: a systematic review of the literature. Orphanet J Rare Dis. 2021;16(1):1-13. doi:10.1186/s13023-020-01625-z
11. Dharmaputra RK, Piesse CM, Chaubey S, Sinha AK, Chiam HC. A rare diagnosis of Langerhans cell histiocytosis made on thyroid histology with coexisting papillary thyroid cancer and AVP deficiency. Endocrinol Diabetes Metab Case Reports. 2024;2024(2). doi:10.1530/EDM-23-0050
12. Alshadwi A, Nadershah M, AlBazie S. Langerhans cell histocytosis of the mandible in a pediatric patient. J Dent Child. 2013;80(3):145-149.
13. Wadone MM, Masgal MM, Anita AM, Rajesh PS. A study of cytomorphological spectrum of head and neck lesions in pediatric age group. J Cytol. 2023;40(2):75-80. doi:10.4103/joc.joc_93_22
14. Sokolovski B, Scolnik M, Malkin L, Postovsky S, Weyl Ben-Arush M, Ilivitzki A. Ultrasound-guided core biopsy with on-site cytology-immediate diagnosis in pediatric oncology. Diagn Cytopathol. 2021;49(7):817-821. doi:10.1002/dc.24746
15. Goyal G, Tazi A, Go RS, et al. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood. 2022;139(17):2601-2621. doi:10.1182/blood.2021014343
16. Allen CE, Ladisch S, McClain KL. How i treat Langerhans cell histiocytosis. Blood. 2015;126(1):26-35. doi:10.1182/blood-2014-12-569301
17. Donadieu J, Henter J-I, Lehrnbecher T, et al. Standard Clinical Practice Recommendations for Pediatric-Onset Langerhans Cell Histiocytosis. Eur Soc Paediatr Oncol Eur Ref Netw Paediatr Oncol. 2020;(1.2).
18. Yoon S, Park S. A study of 77 cases of surgically excised scalp and skull masses in pediatric patients. Child’s Nerv Syst. 2008;24(4):459-465. doi:10.1007/s00381-007-0523-2
19. Ilivitzki A, Sokolovski B, Assalia A, et al. Ultrasound-Guided Core Biopsy for Tissue Diagnosis in Pediatric Oncology: 16-Year Experience With 597 Biopsies. Am J Roentgenol. February 2021:1-8. doi:10.2214/AJR.20.23196
20. Sharan KC, Agarkar L, Jeyaraman R, Radhakrishnan S, Gochhait D. Langerhans cell histiocytosis of thyroid and bilateral parotid diagnosed on fine needle aspiration cytology. Cytopathol Off J Br Soc Clin Cytol. 2024;35(4):515-519. doi:10.1111/cyt.13376
21. Betting T, Benson JC, Madhavan A et al. S. Safety and histopathologic yield of percutaneous CT-guided biopsies of the skull base, orbit, and calvarium [published correction appears in Neuroradiology. 2024 Jul;66(7):1239. doi: 10.1007/s00234-024-03370-7.]. Neuroradiology. 2024;66(3):417-425. doi:10.1007/s00234-023-03266-y
22. Tomasian A, Hillen TJ, Jennings JW. Percutaneous CT-guided skull biopsy: Feasibility, safety, and diagnostic yield. Am J Neuroradiol. 2019;40(2):309-312. doi:10.3174/ajnr.A5949
23. Yanagawa T, Watanabe H, Shinozaki T, Ahmed A, Shirakura K, Takagishi K. The natural history of disappearing bone tumours and tumour-like conditions. Clin Radiol. 2001;56(11):877-886.
24. Kamimura M, Kinoshita T, Itoh H, Yuzawa Y, Takahashi J, Ohtsuka K. Eosinophilic granuloma of the spine: early spontaneous disappearance of tumor detected on magnetic resonance imaging. Case report. J Neurosurg. 2000;93(2):312-316. doi:10.3171/spi.2000.93.2.0312
25. Muscolo D, Slullitel G, Ranalletta M, Aponte-Tinao L, Ayerza M. Spontaneous remission of massive solitary eosinophilic granuloma of the femur. J Pediatr Orthop. 2023;23(6):763-765. doi:10.1097/00004694-200311000-00014
26. Oliveira M, Steinbok P, Wu J, Heran N, Cochrane D. Spontaneous resolution of calvarial eosinophilic granuloma in children. Pediatr Neurosurg. 2003;38(5):247-252. doi:10.1159/000069828
27. Zhang XH, Zhang J, Chen ZH, et al. Langerhans cell histiocytosis of skull: A retrospective study of 18 cases. Ann Palliat Med. 2017;6(2):159-164. doi:10.21037/apm.2016.11.04